Omada Health director gets 991 RSU grant

Omada Health director Trevor Fetter reported an equity award on Form 4.

Accepted by SEC EDGAR 01/07/2026 - 05:36 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Omada Health director Trevor Fetter reported an equity award on Form 4. On January 5, 2026, he received 991 restricted stock units (RSUs) of Omada Health, Inc. common stock at a price of $0 per share under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of common stock, with settlement to occur on a date he selects under the program or as otherwise provided by the program.

After this grant, Fetter beneficially owns 11,696 shares directly and 111,200 shares indirectly through a limited liability company of which he is the sole member.

Insider Trade Summary

Grant/Award: 991 shares

Grant/Award 1 txn

Insider FETTER TREVOR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	991	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 11,696 shares (Direct); Common Stock — 111,200 shares (Indirect, See footnote)

Holdings Before and After: Common Stock, 10,705 to 11,696 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.
2. F2. Shares held by a limited liability company of which the Reporting Person is the sole member.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) disclose in this Form 4 filing?

The filing reports that director Trevor Fetter received an equity award of 991 restricted stock units (RSUs) of Omada Health, Inc. common stock on January 5, 2026 under the company27s Non-Employee Director Compensation Program.

How many Omada Health shares did Trevor Fetter receive and at what price?

Trevor Fetter received 991 RSUs, each representing one share of Omada Health common stock, at a reported price of $0 per share, reflecting an award granted in lieu of cash retainer fees.

What is Trevor Fetter27s total direct ownership in Omada Health after this transaction?

Following the RSU award, Trevor Fetter beneficially owns 11,696 shares of Omada Health common stock directly, as reported in the Form 4.

What indirect Omada Health holdings does Trevor Fetter report in this Form 4?

The Form 4 shows that 111,200 shares of Omada Health common stock are held indirectly through a limited liability company of which Trevor Fetter is the sole member.

How do the reported RSUs for Trevor Fetter settle into Omada Health common stock?

Each reported RSU represents the right to receive one share of Omada Health common stock, with settlement to occur on a date selected by Trevor Fetter under the Non-Employee Director Compensation Program or as otherwise provided by that program.

Why were the RSUs granted to the Omada Health director Trevor Fetter?

The RSUs were granted to Trevor Fetter under Omada Health27s Non-Employee Director Compensation Program in lieu of retainer fees, meaning equity was used instead of cash compensation for his director service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FETTER TREVOR

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/05/2026		A		991(1)	A	$0	11,696	D
Common Stock								111,200(2)	I	See footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

2. Shares held by a limited liability company of which the Reporting Person is the sole member.

	/s/ Nathan Salha, as Attorney-in-Fact for Trevor Fetter	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.